11 – 20 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
The genetic architecture of type 2 diabetes
(
- Contribution to journal › Article
- 2015
-
Mark
MiR-335 regulates exocytotic proteins and affects glucose-stimulated insulin secretion through decreased Ca2+-dependent exocytosis in beta cells
(
- Contribution to journal › Published meeting abstract
-
Mark
Galectin 3 is a powerful risk predictor for recurrent coronary events in acute coronary syndrome patients
(
- Contribution to journal › Published meeting abstract
- 2014
-
Mark
Comparison of MRD monitoring by IG/TR rearrangement and BCR/ABL1 transcript in PH+ pediatric acute lymphoblastic leukemia patients treated with imatinib in the EsPhALL study
(
- Contribution to journal › Published meeting abstract
-
Mark
Theories and myths of European Foreign Policy
2014) p.877-891(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2012
-
Mark
Systematic performance study of common neutron guide geometries
2012) In Nuclear Instruments & Methods in Physics Research. Section A: Accelerators, Spectrometers, Detectors, and Associated Equipment 696. p.75-84(
- Contribution to journal › Article
-
Mark
The business model of solid waste management in Sweden – A case study of two municipally-owned companies
(
- Contribution to journal › Article
-
Mark
Intake estimation of total and individual flavan-3-ols, proanthocyanidins and theaflavins, their food sources and determinants in the European Prospective Investigation into Cancer and Nutrition (EPIC) study
(
- Contribution to journal › Article
-
Mark
Potential implications of future climate and land-cover changes for the fate and distribution of persistent organic pollutants in Europe
(
- Contribution to journal › Article
- 2010
-
Mark
Improved Survival for Multiple Myeloma in Denmark Based on Autologous Stem Cell Transplantation and Novel Drug Therapy in Collaborative Trials: Analysis of Accrual, Prognostic Variables, Selection Bias, and Clinical Behavior on Survival in More Than 1200 Patients in Trials of the Nordic Myeloma Study Group
(
- Contribution to journal › Article